Patient Characteristics
| Characteristic | n = 203 |
| Median age (y) | 64 (range, 44–78) |
| Type of surgery | |
| SLN + ePLND | 49 (24.2%) |
| SLN + ePLND + prostatectomy | 154 (75.8%) |
| D’Amico score | |
| 2 | 163 (80%) |
| 3 | 40 (20%) |
| Tumor stage | |
| T1 | 72 (35.3%) |
| T2a | 90 (44.6%) |
| T2b | 28 (13.7%) |
| T3a | 13 (6.4%) |
| Median initial prostate-specific antigen (ng/mL) | 8 (range, 2–130) |
| <10 | 115 |
| 10–19 | 60 |
| 20–49 | 22 |
| 50–99 | 5 |
| >100 | 1 |
| Gleason biopsy | |
| 6 | 43 |
| 3 + 4 | 105 |
| 4 + 3 | 39 |
| 4 + 4 | 11 |
| 4 + 5 | 5 |
| No. of cores taken | |
| Mean | 19.74 |
| Median | 18 |
| Range | 6–28 |
| Percentages of positive cores (%) | |
| Mean | 39.1 |
| Median | 36 |
| Range | 4–100 |
| Gleason after surgery (154 patients) | |
| 6 | 37 |
| 3 + 4 | 88 |
| 4 + 3 | 20 |
| 4 + 4 | 5 |
| 4 + 5 | 4 |
| Histopathologic stage | |
| pT2 | 78 |
| pT3a | 51 |
| pT3b | 25 |